Search result for ""

May
Disposed 20% interest in Shanghai Information Investment, with HK$775 million divestment proceeds.
June
Acquired 40% equity interest of Shanghai Urban Development (Holdings) Co., Ltd. ("SUDH") for a consideration of about RMB 2,131 million, establishing real estate as one of SIHL's core ...
August
Divested from logistics-related businesses to optimize SIHL's infrastructure business portfolio, realizing a cash income of RMB205 million.
September
Selected as a Hang Seng Index Constituent Stock.
May
Proposed to transfer 5 Chinese medicine assets to SI Pharmaceutical at a total consideration of RMB1,515 million (subsequently discontinued due to regulatory approvals not being obtained).
November
Signed a HK$3 billion syndicated loan.
April
Disposed 10% interest in Waigaoqiao Container Port Phase 1, realizing a cash income of RMB465 million.
December
New drugs "Oncorine", "Kai Li Kang" and "TNF" received State Category One New Drug Certificates by the State Food and Drug Administration.
October
Disposed 28.15% stake in Shanghai Jahwa, realizing a cash income of RMB337 million.
June
Increased General Water of China's registered capital to RMB1 billion.
April
SI Pharmaceutical acquired 40% interest of Shanghai Medical Instruments Co. Ltd. for RMB75.8 million.
April
Invested RMB145 million to increase stakes in Huqingyutang Pharmaceutical and Xiamen TCM; Disposed non-controlling interests in Kehua Biotech, Sunve Pharmaceutical and Helishi Dental, realizing a ...
March
SMIC was listed in U.S. and Hong Kong, raising HK$13.86 billion including HK$7.8 billion from new shares placement.
September
Increased investment in SMIC by US$32 million as part of an SMIC US$636-million private placement, maintaining the single largest shareholder status.
August
Invested RMB 250 million to collaborate with China Energy Conservation Investment Corp. to form General Water of China, which is specialized in making investment in water services projects in China ...
August
Invested RMB 2 billion for 100% interest of Hu-Ning Expressway (Shanghai section), with 25-year operating rights.
August
Following change in government policy, terminated investment in Shanghai Inner Ring Road and North-South Elevated Expressway, and the Yan'an Elevated Road projects. Received full reimbursement of ...
May
Acquired 56.63% equity interests of A-share company SI United and privatized the GEM-listed SIIC MedTech. Total considerations for the two transactions amounted to HK$1.335 billion.
May
Disposed 51% stake in Orient Shopping Center, with RMB127 million divestment proceeds.
April
Acquired 30% of Huqingyutang Pharmaceutical.
1 && $_REQUEST['all'] == ''){ ?>